HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

alpha-fluoro-beta-alanine: effects on the antitumor activity and toxicity of 5-fluorouracil.

Abstract
We have shown previously that (R)-5-fluoro-5,6-dihydrouracil (FUraH(2)) attenuates the antitumor activity of 5-fluorouracil (FUra) in rats bearing advanced colorectal carcinoma. Presently, we found that alpha-fluoro-beta-alanine (FBAL), the predominant catabolite of FUra that is formed rapidly via FUraH(2), also decreased the antitumor activity and potentiated the toxicity of FUra. In rats treated with Eniluracil (5-ethynyluracil, GW776), excess FBAL, in a 9:1 ratio to FUra, produced similar effects when administered 1 hr before, simultaneously with, or 2 hr after FUra. FBAL also decreased the antitumor activity of FUra in Eniluracil-treated mice bearing MOPC-315 myeloma at a 9:1 ratio with FUra, but not at a 2:1 ratio. FBAL did not affect the antitumor activity of FUra in mice bearing Colon 38 tumors. We also evaluated the effect of thymidylate synthase (TS) and thymidine kinase (TK) from tumor extracts after FUra +/- Eniluracil +/- FBAL treatment. The activity of TK was similar among the three groups at both 18 and 120 hr. There was also no difference in TS inhibition ( approximately 35%) at 18 hr. However, significantly more TS inhibition was observed in the Eniluracil/FUra group than in the FUra-alone group at 120 hr. FBAL did not alter the effect of Eniluracil/FUra in TS inhibition. Neither FUraH(2) nor FBAL affected the IC(50) of FUra in culture. Thus, the effect of FBAL did not result from direct competition with FUra uptake or immediate anabolism. Either another downstream catabolite that is not formed in cell culture is the active agent, or the effect requires the complexity of a living organism or an established tumor.
AuthorsS Cao, D P Baccanari, Y M Rustum, S T Davis, R L Tansik, D J Porter, T Spector
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 59 Issue 8 Pg. 953-60 (Apr 15 2000) ISSN: 0006-2952 [Print] England
PMID10692560 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antimetabolites, Antineoplastic
  • beta-Alanine
  • alpha-fluoro-beta-alanine
  • Fluorouracil
Topics
  • Animals
  • Antimetabolites, Antineoplastic (pharmacology, therapeutic use)
  • Colonic Neoplasms (drug therapy)
  • Colorectal Neoplasms (drug therapy)
  • Drug Interactions
  • Female
  • Fluorouracil (pharmacology, therapeutic use)
  • Mice
  • Multiple Myeloma (drug therapy)
  • Neoplasm Transplantation
  • Rats
  • Rats, Inbred F344
  • Tumor Cells, Cultured
  • beta-Alanine (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: